337p亚洲大胆色噜噜|娇喘～爽～白嫩美妇岳|日本dhxxxxx18dh曰本|欧美黄色录象|ass美女洗澡bbwbbw

TheNMPA issued a notice to solicit public opinion on the 《The Application Procedures, Basic Requirements of Application Materials and Key Points of Review for the Re-registration of Drugs Produced in China (Draft for public review)》

Column：Industry News Time：2020-04-30
TheNMPA issued a notice to solicit public opinion on the 《The Application Procedures, Basic Requirements of Application Materials and Key Points of Review for the Re-registration of Drugs Produced in China (Draft for public review)》

2020年04月30日國家藥監局綜合司發布公開征求《境內生產藥品再注冊申報程序、申報資料基本要求和審查要點（征求意見稿）》《境外生產藥品再注冊申報程序、申報資料要求和審查要點（征求意見稿）》意見的通知，意見于2020年5月30日前將境內生產藥品再注冊相關文件意見反饋反饋至電子郵箱yhzcszhc@nmpa.gov.cn，將境外生產藥品再注冊相關文件意見反饋至電子郵箱liup@cde.org.cn。

 

網址鏈接：http://www.nmpa.gov.cn/WS04/CL2138/376948.html